Does Tandem Diabetes Care (NASDAQ:TNDM) Have A Healthy Balance Sheet?
Does Tandem Diabetes Care (NASDAQ:TNDM) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. Importantly, Tandem Diabetes Care, Inc. (NASDAQ:TNDM) does carry debt. But is this debt a concern to shareholders?
作为投资者,一些人认为波动性而非债务是考虑风险最好的方式,但沃伦·巴菲特曾经说过:“波动性远非风险的代名词。”因此当你考虑任何一只股票有多具有风险时,想到债务是很明显的,因为过多的债务会让一家公司陷入困境。重要的是,Tandem Diabetes Care, Inc. (NASDAQ:TNDM)确实有债务。但是这个债务是否令股东担忧呢?
When Is Debt A Problem?
什么时候负债才是一个问题?
Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.
当企业无法通过自由现金流或者通过优惠的价格筹集资金来轻松履行这些债务时,债务和其他负债对于企业就会形成风险。最终,如果公司无法履行其法定的偿还债务的义务,股东可能什至一无所有。不过,更频繁的(但仍然代价高昂)情况是,公司必须以非常低的价格发行股票,永久性地稀释股东的股份,以维持其资产负债表的平衡。话虽如此,大多数情况下,公司会合理地处理债务,并依照企业自身的优势来运用借款。考虑企业使用多少债务时需要做的第一件事是查看其现金和债务的总和。
What Is Tandem Diabetes Care's Debt?
Tandem Diabetes Care的债务是多少?
You can click the graphic below for the historical numbers, but it shows that as of March 2024 Tandem Diabetes Care had US$347.5m of debt, an increase on US$283.7m, over one year. However, its balance sheet shows it holds US$467.8m in cash, so it actually has US$120.3m net cash.
点击下面的图表可查看历史数字,但它显示截至2024年3月,Tandem Diabetes Care负有3.475亿美元的债务,相比一年前的2.837亿美元增加。然而,其资产负债表显示其持有4.678亿美元的现金,因此实际上它拥有1.203亿美元的净现金。
![debt-equity-history-analysis](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240703/0-87823d15a02f6a9f8a3a47ae34fd8c0c-0-6f9ccf7abf4d74c93dc9c1d78e61f654.png/big)
A Look At Tandem Diabetes Care's Liabilities
查看Tandem Diabetes Care的负债情况
The latest balance sheet data shows that Tandem Diabetes Care had liabilities of US$193.0m due within a year, and liabilities of US$505.0m falling due after that. Offsetting this, it had US$467.8m in cash and US$93.0m in receivables that were due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by US$137.2m.
最新的资产负债表数据显示,Tandem Diabetes Care有1.93亿美元的负债在一年内到期,并且有5.05亿美元的负债在此之后到期。与此相应的是,它持有4.678亿美元的现金和0.93亿美元的应收账款,这些账款将在12个月内到期。因此,其负债超过其现金和(短期)应收账款的总和1.372亿美元。鉴于Tandem Diabetes Care的市值为25.5亿美元,很难相信这些负债会构成多大的威胁。话虽如此,很明显我们应该继续关注其资产负债表,以免情况变得更糟。尽管它有显著的负债,但Tandem Diabetes Care拥有净现金,因此可以说它的债务负担并不重!当分析债务时,资产负债表很明显是需要关注的领域。但是最终,业务未来的盈利能力将决定Tandem Diabetes Care是否能够随着时间推移加强其资产负债表。因此,如果你关注未来,请查看这份免费的分析师利润预测报告。
Given Tandem Diabetes Care has a market capitalization of US$2.55b, it's hard to believe these liabilities pose much threat. Having said that, it's clear that we should continue to monitor its balance sheet, lest it change for the worse. Despite its noteworthy liabilities, Tandem Diabetes Care boasts net cash, so it's fair to say it does not have a heavy debt load! The balance sheet is clearly the area to focus on when you are analysing debt. But ultimately the future profitability of the business will decide if Tandem Diabetes Care can strengthen its balance sheet over time. So if you're focused on the future you can check out this free report showing analyst profit forecasts.
在12个月内,Tandem Diabetes Care在EBIT层面上亏损,并且其营业收入下降到7.7亿美元,下降了3.1%。我们更希望看到增长。鉴于Tandem Diabetes Care的市值为25.5亿美元,很难相信这些负债会构成多大的威胁。话虽如此,很明显我们应该继续关注其资产负债表,以免情况变得更糟。尽管它有显著的负债,但Tandem Diabetes Care拥有净现金,因此可以说它的债务负担并不重!当分析债务时,资产负债表很明显是需要关注的领域。但是最终,业务未来的盈利能力将决定Tandem Diabetes Care是否能够随着时间推移加强其资产负债表。因此,如果你关注未来,请查看这份免费的分析师利润预测报告。
Over 12 months, Tandem Diabetes Care made a loss at the EBIT level, and saw its revenue drop to US$770m, which is a fall of 3.1%. We would much prefer see growth.
在12个月内,Tandem Diabetes Care在EBIT层面上亏损,并且其营业收入下降到7.7亿美元,下降了3.1%。我们更希望看到创业板。
So How Risky Is Tandem Diabetes Care?
Tandem Diabetes Care有多大风险?
By their very nature companies that are losing money are more risky than those with a long history of profitability. And the fact is that over the last twelve months Tandem Diabetes Care lost money at the earnings before interest and tax (EBIT) line. And over the same period it saw negative free cash outflow of US$67m and booked a US$141m accounting loss. While this does make the company a bit risky, it's important to remember it has net cash of US$120.3m. That means it could keep spending at its current rate for more than two years. Summing up, we're a little skeptical of this one, as it seems fairly risky in the absence of free cashflow. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. For example - Tandem Diabetes Care has 2 warning signs we think you should be aware of.
按照它们的本质,那些亏损的公司比那些具有长期盈利历史的公司更加冒险。事实上,在过去的十二个月中,tandem diabetes care在利息和税前利润(EBIT)方面亏损了资金,并且在同期内它看到了6700万美元的负自由现金流出口,并记录了1.41亿美元的会计亏损。虽然这使该公司有点冒险,但重要的是要记住它有1.203亿美元的净现金。这意味着它可以以当前速度继续支出两年以上。总的来说,在缺乏自由现金流的情况下,我们对这个问题有些怀疑。在分析债务水平时,资产负债表是一个明显的起点。但最终,每个公司都可能存在超出资产负债表之外的风险。例如- Tandem Diabetes Care公司有2个警告信号,我们认为您应该知道。
If you're interested in investing in businesses that can grow profits without the burden of debt, then check out this free list of growing businesses that have net cash on the balance sheet.
如果您有兴趣投资能够在不负债的情况下增长利润的企业,请查看这份免费列表,其中列出了在资产负债表上拥有净现金的成长型企业。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?关于内容有所顾虑?直接和我们联系。或电邮 editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,也可以发送电子邮件至editorial-team@simplywallst.com